• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CERNER CORPORATION MPAGES; SOFTWARE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CERNER CORPORATION MPAGES; SOFTWARE Back to Search Results
Model Number MPAGES 6.12 - 6.14
Device Problem Application Program Problem (2880)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/23/2019
Event Type  malfunction  
Manufacturer Narrative
Cerner distributed a flash notification on january 10, 2020 to all potentially impacted client sites.The software notification includes a description of the issue and a software modification is being developed to address the issue for all sites that could be potentially impacted.
 
Event Description
The software product mentioned in this medwatch report may not be, by definition, a medical device; however, cerner has chosen to file this medwatch report in order to voluntarily notify the fda of a malfunction associated with this software product.The company's filing of this medwatch report does not signify cerner's belief or understanding that medical device reports are required to be filed for products such as cerner's mpages®, nor are these products currently actively regulated by the fda.This report documents information related to an issue identified with functionality included in cerner's millennium mpages® opioid review.The issue involves cerner millennium mpages and affects users that utilize the opioid review to prescribe orders.When a physician places a primary opioid inpatient or prescription order using powerorders, for medications with multiple morphine milligram equivalent (mme) conversion factors, the mme column may display an incorrect value which may be used for future opioid order decision making.Patient care can be affected if a physician prescribes or does not prescribe opioid medication to a patient based on incorrect opioid ordering information.The issue is limited to the following medications: buprenorphine, butorphanol, fentanyl, hydromorphone, meperidine, and morphine.Cerner has not received communication on any adverse patient events as a result of this issue.
 
Manufacturer Narrative
Cerner distributed a flash notification on june 18,2020 to all potentially impacted client sites.The software notification includes a description of the issue and a software modification has been developed to address the issue for all sites that could be potentially impacted.Cerner corporation considers this issue to be resolved and no further narrative is required for follow-up.
 
Event Description
The software product mentioned in this medwatch report may not be, by definition, a medical device; however, cerner has chosen to file this medwatch report in order to voluntarily notify the fda of a malfunction associated with this software product.The company's filing of this medwatch report does not signify cerner's belief or understanding that medical device reports are required to be filed for products such as cerner's mpages®, nor are these products currently actively regulated by the fda.This report documents information related to an issue identified with functionality included in cerner's millennium mpages® opioid review.The issue involves cerner millennium mpages and affects users that utilize the opioid review to prescribe orders.When a physician places a primary opioid inpatient or prescription order using power orders, for medications with multiple morphine milligram equivalent (mme) conversion factors, the mme column may display an incorrect value which may be used for future opioid order decision making.Patient care can be affected if a physician prescribes or does not prescribe opioid medication to a patient based on incorrect opioid ordering information.The issue is limited to the following medications: buprenorphine, butorphanol, fentanyl, hydromorphone, meperidine, and morphine.Cerner has not received communication on any adverse patient events as a result of this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MPAGES
Type of Device
SOFTWARE
Manufacturer (Section D)
CERNER CORPORATION
2800 rock creek parkway
kansas city, mo MO 64117
MDR Report Key9593862
MDR Text Key204194719
Report Number1931259-2020-00001
Device Sequence Number1
Product Code LNX
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Remedial Action Notification
Type of Report Initial,Followup
Report Date 06/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMPAGES 6.12 - 6.14
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-